Arena Pharmaceuticals, Inc. (ARNA)

[groverisproud]

If the FDA does not announce a delay for Lorcaserin's approval date in the next few days, wouldn't it be fairly safe to assume that the drug will be approved on the 27th? To me no delay indicates that the FDA has no more concerns they require that ARNA address and Colman seemed to be pleased with the drug's efficacy so no worries there. I know that the FDA is totally unpredictable, but with so much focus on fighting obesity (with Dr. Margaret Hamburg - commissioner of FDA and First Lady Michelle both viewing it as a high priority) it seems it would be impossible for the FDA to reject Lorcaserin. If they did they would get MAJOR backlash from the masses unless they have any serious concerns about the drug (which I assume would result in a delay and which I also assume would have been brought up at the ADCOMM review). My roundabout question here is don't you think it would be safe to assume that if we can make it to the 26th with no delay we all ought to feel confident in holding onto our shares and sleeping well through the night of the 26th?